Masimo won FDA clearance for its Next Generation SedLine brain function monitoring, a system for assessing the brain while under anesthesia. Next Generation SedLine relies on four EEG (electroencephalography) leads that acquire brain signals from both sides of the brain. The new version of the offering includes an improved signal processing engine that can help anesthesiologists have a better idea of what’s going on inside the cranium. The new engine produces a newly tuned Patient State Index (PSi) the readings from which can be easily integrated into a physician’s decision making process.
The product also produces Multitaper Density Spectral Array (DSA), an indicator created by Dr. Emery Brown, MD, PhD, and Dr. Patrick Purdon, PhD of the Neuroscience Statistics Research Lab at Massachusetts General Hospital. This indicator converts EEG readings into the frequency domain, providing a different look at the brain data and making it easier to understand.
The readings obtained with the Next Generation SedLine can be gathered at the same time along with O3 regional oximetry, helping to assess cerebral oxygenation, on Masimo’s Root patient monitoring system.